Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2016 (2016), Article ID 6549268, 3 pages
http://dx.doi.org/10.1155/2016/6549268
Case Report

Acute Hemolysis with Renal Failure due to Clostridium Bacteremia in a Patient with AML

Department of Internal Medicine, Texas Tech University Health Sciences Center, 3601 4th Street, MS 9410, Lubbock, TX 79430, USA

Received 9 June 2016; Accepted 7 September 2016

Academic Editor: Daniela M. Cirillo

Copyright © 2016 R. M. Medrano-Juarez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. A. Uzal, J. C. Freedman, A. Shrestha et al., “Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease,” Future Microbiology, vol. 9, no. 3, pp. 361–377, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Sakurai, M. Nagahama, and M. Oda, “Clostridium perfringens alpha-toxin: characterization and mode of action,” Journal of Biochemistry, vol. 136, no. 5, pp. 569–574, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. C. C. van Bunderen, M. K. Bomers, E. Wesdorp, P. Peerbooms, and J. Veenstra, “Clostridium perfringens septicaemia with massive intravascular haemolysis: a case report and review of the literature,” Netherlands Journal of Medicine, vol. 68, no. 9, pp. 343–346, 2010. View at Google Scholar · View at Scopus
  4. C.-C. Yang, P.-C. Hsu, H.-J. Chang, C.-W. Cheng, and M.-H. Lee, “Clinical significance and outcomes of Clostridium perfringens bacteremia—a 10-year experience at a tertiary care hospital,” International Journal of Infectious Diseases, vol. 17, no. 11, pp. e955–e960, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. E. Mirrakhimov, G. Chandra, P. Voore et al., “Clostridium perfringens bacteremia in an 85-year-old diabetic man,” Case Reports in Gastroenterology, vol. 8, no. 3, pp. 404–407, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Banaszkiewicz, J. Kadzielska, A. Gawrońska et al., “Enterotoxigenic Clostridium perfringens infection and pediatric patients with inflammatory bowel disease,” Journal of Crohn's and Colitis, vol. 8, no. 4, pp. 276–281, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Atia, T. Raiyani, P. Patel, R. Patton, and M. Young, “Clostridium perfringens bacteremia caused by choledocholithiasis in the absence of gallbladder stones,” World Journal of Gastroenterology, vol. 18, no. 39, pp. 5632–5634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. M. Rechner, W. A. Agger, K. Mruz, and T. H. Cogbill, “Clinical features of clostridial bacteremia: a review from a rural area,” Clinical Infectious Diseases, vol. 33, no. 3, pp. 349–353, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Schwan and A. C. Ryden, “The clinical importance of anaerobic bacteria in wound infections after gastrointestinal surgery,” Scandinavian Journal of Infectious Diseases, vol. 10, no. 2, pp. 119–125, 1978. View at Publisher · View at Google Scholar · View at Scopus
  10. G. P. Bodey, S. Rodriguez, V. Fainstein, and L. S. Elting, “Clostridial bacteremia in cancer patients. A 12-year experience,” Cancer, vol. 67, no. 7, pp. 1928–1942, 1991. View at Publisher · View at Google Scholar · View at Scopus
  11. H.-L. Lee, S.-Y. Cho, D.-G. Lee et al., “A fatal spontaneous gas gangrene due to Clostridium perfringens during neutropenia of allogeneic stem cell transplantation: case report and literature review,” Infection and Chemotherapy, vol. 46, no. 3, pp. 199–203, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Renaudon-Smith, M. Kaur, A. Haroon, J. Cavenagh, and T. Butler, “Intravascular haemolysis secondary to Clostridium perfringens in a patient with acute myeloid leukaemia undergoing allogeneic stem cell transplantation,” British Journal of Haematology, vol. 165, no. 6, p. 743, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. T. G. Simon, J. Bradley, A. Jones, and G. Carino, “Massive intravascular hemolysis from clostridium perfringens septicemia: a review,” Journal of Intensive Care Medicine, vol. 29, no. 6, pp. 327–333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. T. Pirrotta, A. Bucalossi, F. Forconi et al., “Massive intravascular hemolysis: a fatal complication of Clostridium perfringens septicemia in a patient with acute lymphoblastic leukemia,” Leukemia & Lymphoma, vol. 46, no. 5, p. 793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Vaiopoulos, C. Calpadaki, H. Sinifakoulis et al., “Massive intravascular hemolysis: a fatal complication of clostridium perfringens septicemia in a patient with acute myeloid leukemia,” Leukemia and Lymphoma, vol. 45, no. 10, pp. 2157–2159, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Ifthikaruddin and J. A. Holmes, “Clostridium perfringens septicaemia and massive intravascular haemolysis as a terminal complication of autologous bone marrow transplant,” Clinical and Laboratory Haematology, vol. 14, no. 2, pp. 159–161, 1992. View at Google Scholar · View at Scopus
  17. J. R. Kapoor, B. Monteiro, L. Tanoue, and M. D. Siegel, “Massive intravascular hemolysis and a rapidly fatal outcome,” Chest, vol. 132, no. 6, pp. 2016–2019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. L. Stevens, K. A. Maier, and J. E. Mitten, “Effect of antibiotics on toxin production and viability of Clostridium perfringens,” Antimicrobial Agents and Chemotherapy, vol. 31, no. 2, pp. 213–218, 1987. View at Publisher · View at Google Scholar · View at Scopus